Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06786429 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06786429 · ClinicalTrials.gov record · last posted 2026-07-30

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

StatusNot Yet Recruiting
PhasePhase 4
Started2027-01-30
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Aim: The main goal of this quantitative epidemiological observational study is to determine the prevalence of Human Papilloma Virus (HPV) infection and Hepatitis B (Hep B) immunity amongst women of childbearing age. attending clinics at Mtshabezi Mission and Matobo clinic respectively, and assessing behavioral risk factors of high school students at these catchment areas that can put them at risk for developing cancer of the cervix and liver. Question: Can screening for cancer, vaccination against Hep B and HPV, and cognitive behavior intervention help in preventing related cancers amongst these groups of participants?

Protocol amendment history 3 changes detected by DataLookout

2026-07-31
Enrollment increased: 1800 → 2140 participants
2026-07-31
Primary completion pushed: 2031-09-30 → 2032-12-15
2026-07-31
Completion pushed: 2031-12-30 → 2032-12-15
Trial Details
NCT Number NCT06786429
Lead Sponsor Eunice Dube
Collaborators: National University of Science and Technology, Zimbabwe, Brethren in Christ Church Health System, Abazukulu Health Research and Development Project
Conditions Hepatitis B, Human Papilloma Virus, Mental Health Issue, Cancer Liver, Cancer of Cervix, Depression, Anxiety
Enrollment 2,140 participants
Start Date 2027-01-30
Primary Completion 2032-12-15 (estimated)
Study Completion 2032-12-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-30